The consumer-genomics company 23andMe just sold its biobank of customer genetic data to drugmaker Regeneron for $256 million.

Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.

  • AernaLingus [any]English
    40•25 days ago

    Shoutout to my dumbass relatives for sending their DNA to this company—thanks for nothing!